Combined deficiency of proapoptotic regulators Bim and Fas results in the early onset of systemic autoimmunity

被引:177
作者
Hutcheson, Jack [1 ,2 ]
Scatizzi, John C. [1 ,3 ]
Siddiqui, Akbar M. [1 ]
Haines, G. Kenneth, III [4 ]
Wu, Tianfu [2 ]
Li, Quan-Zhen [2 ]
Davis, Laurie S. [2 ]
Mohan, Chandra [2 ]
Perlman, Harris [1 ]
机构
[1] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA
[2] Univ Texas SW Med Ctr Dallas, Ctr Immunol, Dept Rheumatol & Internal Med, Dallas, TX 75390 USA
[3] Univ Calif San Diego, Sch Med, Dept Rheumatol Allergy & Immunol, La Jolla, CA 92093 USA
[4] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA
关键词
D O I
10.1016/j.immuni.2007.12.015
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Alterations in the stoichiometric balance between members of Bcl-2 and Fas apoptotic pathway could lead to the pathogenesis of systemic lupus erythematosus (SLE). We showed that patients with SLE displayed increased expression in antiapoptotic members of the Bcl-2 and Fas apoptotic pathways in isolated mononuclear cells. Further, mice (Bcl2l11(-/-) Fas(lpr/lpr) lacking the Bcl-2 pro-apoptotic member, Bim (Bcl2l11(-/-)) and and with an lpr mutation in the gene encoding Fas (Fas(lpr/lpr)) developed severe SLE-like disease by 16 weeks of age unlike Bcl2l11(-/-) or Fas(lpr/lpr) mice. Bcl2l11(-/-)Fas(lpr/lpr) antigen-presenting cells (APCs) were markedly activated, and their numbers were increased in lymphoid tissues and in kidneys, yet numerous TUNEL-positive cells were observed in glomeruli of Bcl2l11(-/-)Fas(lpr/lpr) mice. These data demonstrate that dysreaulation of the Bcl-2 or Fas pathways can alter the function of APCs, thereby leading to SLE pathogenesis.
引用
收藏
页码:206 / 217
页数:12
相关论文
共 41 条
  • [1] MESANGIAL CELL APOPTOSIS - THE MAJOR MECHANISM FOR RESOLUTION OF GLOMERULAR HYPERCELLULARITY IN EXPERIMENTAL MESANGIAL PROLIFERATIVE NEPHRITIS
    BAKER, AJ
    MOONEY, A
    HUGHES, J
    LOMBARDI, D
    JOHNSON, RJ
    SAVILL, J
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (05) : 2105 - 2116
  • [2] Interferon and granulopoiesis signatures in systemic lupus erythematosus blood
    Bennett, L
    Palucka, AK
    Arce, E
    Cantrell, V
    Borvak, J
    Banchereau, J
    Pascual, V
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (06) : 711 - 723
  • [3] DERIVATION OF THE SLEDAI - A DISEASE-ACTIVITY INDEX FOR LUPUS PATIENTS
    BOMBARDIER, C
    GLADMAN, DD
    UROWITZ, MB
    CARON, D
    CHANG, CH
    [J]. ARTHRITIS AND RHEUMATISM, 1992, 35 (06): : 630 - 640
  • [4] Degenerative disorders caused by Bcl-2 deficiency prevented by loss of its BH3-only antagonist bim
    Bouillet, P
    Cory, S
    Zhang, LC
    Strasser, A
    Adams, JM
    [J]. DEVELOPMENTAL CELL, 2001, 1 (05) : 645 - 653
  • [5] Proapoptotic Bcl-2 relative bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity
    Bouillet, P
    Metcalf, D
    Huang, DCS
    Tarlinton, DM
    Kay, TWH
    Köntgen, F
    Adams, JM
    Strasser, A
    [J]. SCIENCE, 1999, 286 (5445) : 1735 - 1738
  • [6] Fas death receptor signaling represses monocyte numbers and macrophage activation in vivo
    Brown, NJ
    Hutcheson, J
    Bickel, E
    Scatizzi, JC
    Albee, LD
    Haines, GK
    Eslick, J
    Bradley, K
    Taricone, E
    Perlman, H
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 173 (12) : 7584 - 7593
  • [7] Regulation of Bim by TCR signals in CD4/CD8 double-positive thymocytes
    Bunin, A
    Khwaja, FW
    Kersh, GJ
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 175 (03) : 1532 - 1539
  • [8] Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function
    Chen, L
    Willis, SN
    Wei, A
    Smith, BJ
    Fletcher, JI
    Hinds, MG
    Colman, PM
    Day, CL
    Adams, JM
    Huang, DCS
    [J]. MOLECULAR CELL, 2005, 17 (03) : 393 - 403
  • [9] Apoptotic cell death and lupus
    Cohen, Philip L.
    [J]. SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 2006, 28 (02): : 145 - 152
  • [10] LPR AND GLD - SINGLE GENE MODELS OF SYSTEMIC AUTOIMMUNITY AND LYMPHOPROLIFERATIVE DISEASE
    COHEN, PL
    EISENBERG, RA
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1991, 9 : 243 - 269